logo
Analysts Offer Insights on Communication Services Companies: TPG Telecom Limited (OtherTPGTF) and REA Group Ltd (OtherRPGRF)

Analysts Offer Insights on Communication Services Companies: TPG Telecom Limited (OtherTPGTF) and REA Group Ltd (OtherRPGRF)

Companies in the Communication Services sector have received a lot of coverage today as analysts weigh in on TPG Telecom Limited (TPGTF – Research Report) and REA Group Ltd (RPGRF – Research Report).
Protect Your Portfolio Against Market Uncertainty
TPG Telecom Limited (TPGTF)
In a report issued on May 7, Tom Beadle from Jarden maintained a Buy rating on TPG Telecom Limited, with a price target of A$5.10. The company's shares closed last Friday at $2.95, equals to its 52-week low of $2.95.
According to TipRanks.com, Beadle is a 1-star analyst with an average return of -1.4% and a 55.3% success rate. Beadle covers the NA sector, focusing on stocks such as Telstra Corporation Limited, REA Group Ltd, and Seek Limited.
The word on The Street in general, suggests a Hold analyst consensus rating for TPG Telecom Limited with a $3.18 average price target.
Morgans analyst Steven Sassine maintained a Hold rating on REA Group Ltd today and set a price target of A$250.00. The company's shares closed last Monday at $149.00.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Analysts Offer Insights on Technology Companies: Sensata (ST) and Develop Global Limited (OtherVTEXF)
Analysts Offer Insights on Technology Companies: Sensata (ST) and Develop Global Limited (OtherVTEXF)

Business Insider

time16 hours ago

  • Business Insider

Analysts Offer Insights on Technology Companies: Sensata (ST) and Develop Global Limited (OtherVTEXF)

There's a lot to be optimistic about in the Technology sector as 2 analysts just weighed in on Sensata (ST – Research Report) and Develop Global Limited (VTEXF – Research Report) with bullish sentiments. Confident Investing Starts Here: Sensata (ST) TD Cowen analyst Joseph C Giordano maintained a Buy rating on Sensata yesterday and set a price target of $45.00. The company's shares closed last Monday at $25.70, close to its 52-week low of $24.42. According to Giordano is a 5-star analyst with an average return of 7.7% and a 60.7% success rate. Giordano covers the Industrial Goods sector, focusing on stocks such as Watts Water Technologies, Veralto Corporation, and Rockwell Automation. Currently, the analyst consensus on Sensata is a Hold with an average price target of $28.30. Develop Global Limited (VTEXF) In a report issued on May 29, Tim McCormack from Canaccord Genuity maintained a Buy rating on Develop Global Limited, with a price target of A$5.05. The company's shares closed last Tuesday at $1.40. According to McCormack is a top 100 analyst with an average return of 22.7% and a 66.5% success rate. McCormack covers the Basic Materials sector, focusing on stocks such as Northern Star Resources Ltd, Ramelius Resources Limited, and Gascoyne Resources Limited. Currently, the analyst consensus on Develop Global Limited is a Moderate Buy with an average price target of $2.92.

Analysts Offer Insights on Technology Companies: PagerDuty (PD) and AvePoint (AVPT)
Analysts Offer Insights on Technology Companies: PagerDuty (PD) and AvePoint (AVPT)

Business Insider

time2 days ago

  • Business Insider

Analysts Offer Insights on Technology Companies: PagerDuty (PD) and AvePoint (AVPT)

Companies in the Technology sector have received a lot of coverage today as analysts weigh in on PagerDuty (PD – Research Report) and AvePoint (AVPT – Research Report). Confident Investing Starts Here: PagerDuty (PD) Monness analyst Brian White maintained a Hold rating on PagerDuty on May 30. The company's shares closed last Friday at $14.26. According to White is a top 100 analyst with an average return of 17.7% and a 67.1% success rate. White covers the Technology sector, focusing on stocks such as Salesforce, Snowflake, and MongoDB. Currently, the analyst consensus on PagerDuty is a Hold with an average price target of $18.70, implying a 24.8% upside from current levels. In a report issued on May 21, TD Cowen also maintained a Hold rating on the stock with a $18.00 price target. AvePoint (AVPT) The company's shares closed last Friday at $18.65, close to its 52-week high of $19.90. According to Wood is a 5-star analyst with an average return of 15.0% and a 62.4% success rate. Wood covers the Technology sector, focusing on stocks such as Onestream, Inc. Class A, Klaviyo, Inc. Class A, and Rimini Street. Currently, the analyst consensus on AvePoint is a Strong Buy with an average price target of $21.00.

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Bristol-Myers Squibb (BMY)
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Bristol-Myers Squibb (BMY)

Business Insider

time2 days ago

  • Business Insider

Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and Bristol-Myers Squibb (BMY)

Analysts fell to the sidelines weighing in on Arvinas Holding Company (ARVN – Research Report) and Bristol-Myers Squibb (BMY – Research Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks. Confident Investing Starts Here: Arvinas Holding Company (ARVN) Oppenheimer analyst Matthew Biegler reiterated a Hold rating on Arvinas Holding Company yesterday. The company's shares closed last Friday at $7.20. According to Biegler 's ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -14.6% and a 28.7% success rate. Biegler covers the Healthcare sector, focusing on stocks such as Acrivon Therapeutics, Inc., Day One Biopharmaceuticals, and Zentalis Pharmaceuticals. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Arvinas Holding Company with a $14.66 average price target, implying a 95.5% upside from current levels. In a report released yesterday, Leerink Partners also downgraded the stock to Hold with a $9.00 price target. Bristol-Myers Squibb (BMY) Bernstein analyst Courtney Breen maintained a Hold rating on Bristol-Myers Squibb on May 31. The company's shares closed last Friday at $48.28. According to Breen is a 2-star analyst with an average return of -0.1% and a 27.8% success rate. Breen covers the Healthcare sector, focusing on stocks such as Merck & Company, Gilead Sciences, and Eli Lilly & Co. The word on The Street in general, suggests a Hold analyst consensus rating for Bristol-Myers Squibb with a $55.53 average price target, representing a 16.0% upside. In a report issued on May 16, BMO Capital also maintained a Hold rating on the stock with a $53.00 price target.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store